Coverage, Reimbursement Still Difficult for New Lab Tests

CEO SUMMARY: Bringing a new proprietary diagnostic test to market is an arduous process. It takes patience and planning to complete the journey from test development to payer reimbursement. This slow process stems from the fact that the healthcare reimbursement system is fragmented, with the three main segments being Medicare, Medicaid, and private payers, each …

Coverage, Reimbursement Still Difficult for New Lab Tests Read More »

To access this post, you must purchase The Dark Report.

Coverage, Reimbursement Still Difficult for New Lab Tests

When considering new tests, health insurers want adequate data on test accuracy and clinical value

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month